Maverick Vascular Technologies

Maverick Vascular Technologies is developing the first drug-eluting bioresorbable vascular scaffolds (“BVS”) and the first dual drug-eluting bioresorbable coating for coronary and peripheral applications. Uniquely, the Maverick scaffolds are the only BVS that act to repress inflammation and promote endothelial recovery post-implant, while also inhibiting neointimal (restenotic) response. No other BVS in development have a combination of anti-inflammatory and anti-proliferative properties. Maverick’s technology provides pharmaceutical therapy to the vessel throughout the entire time the Maverick stents are resorbed by the body. These are true Bio-Pharma vascular implants.

Check It Out

For additional information,

please complete this form or email

our Investor Relations team

at [email protected]

I'd like to receive investment information

Maverick Vascular Technologies

The Next Wave in Vascular Restoration

Keep up to date

Subscribe to our Newsletter

Sign me up!